发明名称 THIADIAZOLYL UREA OR THIOUREA DERIVATIVES FOR ANTIVIRAL TREATMENT
摘要 <p>A pharmaceutical composition that inhibits or slows the growth of viruses in animals, particularly in mammals, is disclosed. This same composition can be used to treat viral infections, particularly hepatitis C, herpes simplex, Kaposi's sarcoma and HIV. The composition preferably comprises from about 10 mg to about 6000 mg of a (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or (5-aryl-1,2,4,-thiadiazol)-3-yl urea derivative of formula (I), wherein X is oxygen or sulfur, R is hydrogen or alkyl having from 1-3 carbons, n is 0-4, R1 is independently selected from the group consisting of hydrogen, alkyl having from 1 to 7 carbon atoms, chloro, bromo or fluoro, oxychloro, alkoxy having the formula -O(CH2)yCH3 wherein y is from 1 to 6, or a pharmaceutically acceptable acid addition salt or prodrug thereof. The preferred compound is (5-phenyl-1,2,4-thiadazol-3-yl) thiourea.</p>
申请公布号 WO2000057878(A1) 申请公布日期 2000.10.05
申请号 US2000008421 申请日期 2000.03.29
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址